Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Liabilities and Shareholders Equity: 2021-2023

Historic Liabilities and Shareholders Equity for Zymeworks (ZYME) over the last 1 years, with Sep 2023 value amounting to $556.4 million.

  • Zymeworks' Liabilities and Shareholders Equity rose 85.29% to $556.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.4 billion, marking a year-over-year change of. This contributed to the annual value of $648.7 million for FY2022, which is 66.71% up from last year.
  • Latest data reveals that Zymeworks reported Liabilities and Shareholders Equity of $556.4 million as of Q3 2023, which was down 7.59% from $602.1 million recorded in Q2 2023.
  • In the past 5 years, Zymeworks' Liabilities and Shareholders Equity registered a high of $648.7 million during Q4 2022, and its lowest value of $300.3 million during Q3 2022.
  • For the 3-year period, Zymeworks' Liabilities and Shareholders Equity averaged around $516.2 million, with its median value being $578.6 million (2023).
  • Data for Zymeworks' Liabilities and Shareholders Equity shows a peak YoY skyrocketed of 85.29% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Zymeworks' Liabilities and Shareholders Equity stood at $389.1 million in 2021, then spiked by 66.71% to $648.7 million in 2022, then surged by 85.29% to $556.4 million in 2023.
  • Its Liabilities and Shareholders Equity stands at $556.4 million for Q3 2023, versus $602.1 million for Q2 2023 and $600.7 million for Q1 2023.